Content equals the label
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
B2B Documentation Support
Use this page to align sourcing files, quotation scope, packaging, and buyer-side review before comparing supplier options.
CJC-1295 without DAC (Modified GRF 1-29) as a 5mg lyophilized vial for qualified B2B sourcing, with batch COA, custom fill discussion, and documentation review.
Key Review Snapshot
Why buyers trust WUMO
In this market, “99% pure” is often quoted while the amount actually delivered is far less. We keep purity and real content separate, and put both on paper — so CJC-1295 without DAC 5mg Lyophilized Peptide Vial is backed by documents you can check.
Research peptide line — typical purity >99.3–99.4%, every batch MS-checked before release.
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
Identity and quality are confirmed by batch documentation — COA, plus HPLC / MS where applicable — before material is released.
Ingredient identity (INCI / CAS), specification sheet and SDS are available for review. Match the documents to your quoted batch before you commit.
Documents Available
COA
Batch-level quality summary for buyer-side file review.
Request this file through the inquiry path below.
HPLC
Purity profile reference for the quoted project or batch where available.
Request this file through the inquiry path below.
MS
Identity confirmation support for documentation review where available.
Request this file through the inquiry path below.
SDS
Safety document requested for internal purchasing and handling review.
Request this file through the inquiry path below.
Spec
Product or packaging specification reference for quotation alignment.
Request this file through the inquiry path below.
Overview
B2B Review Guide
Modified GRF (1-29) is supplied as a lyophilized research peptide in a 5mg vial format for qualified B2B sourcing projects. Fill quantity, vial format, packaging, and documentation scope are set per project. This page describes sourcing and analytical documentation only; it does not describe biological action, end-user application, or product performance.
In the commercial peptide market, Modified GRF (1-29) is commonly listed as “CJC-1295 without DAC”. In the original literature, CJC-1295 refers to the analog carrying a Drug Affinity Complex modification. The two materials are chemically different, and the shortened trade name does not distinguish them.
The practical consequence is that a product title alone does not tell a buyer which molecule is being quoted. Confirm the form on the COA and the mass-spectrometry identity record rather than in the catalogue name. If two suppliers quote very different prices for “CJC-1295”, check first whether they are quoting the same material.
CAS numbering does not settle it either. Catalogue entries for this material carry more than one CAS number in circulation, and the same numbers are sometimes applied to the DAC-modified form. That is why no CAS number is stated on this page — an identity record is the reliable check.
A batch-specific COA is issued for the batch being supplied and states the RP-HPLC and mass-spectrometry results for that batch. Purity and peptide content are separate specifications — see what a 10mg vial actually contains for the distinction and what a per-vial claim needs behind it.
Karl Fischer water content, counter-ion form, and appearance are not part of the standard vial COA scope and are arranged per project where a buyer specification requires them. Ask for the COA of the batch being quoted, and check that the batch identifier on it matches the vial label.
This page is for qualified B2B technical evaluation and business-side documentation review only. Material is supplied for research and laboratory use. It is not intended for individual purchase, consumer use, or product-use guidance, and WUMO does not provide medical guidance or outcome claims. Final use, importation, labeling, and local compliance are the buyer's responsibility.
Ask for the batch COA and the mass-spectrometry identity record before comparing prices. The two materials differ in molecular weight, so an identity record settles the question; a trade name or catalogue CAS number does not.
Because more than one CAS number is in circulation for this material, and the same numbers are sometimes applied to the DAC-modified form. Quoting one would give false precision. Use the identity record instead.
5mg per vial is the standard fill on this page. Other fill quantities and vial formats are set per project — share your target fill and vial count and it can be confirmed together with MOQ and lead time.
Company and business type, destination market, intended business use, required documentation package, target fill quantity and estimated volume, packaging preference, and required timeline.
OEM / Private Label
For finished lyophilized peptide vials with custom labels and packaging -- covering MOQ, sample or pilot evaluation, and batch documentation such as COA, sterility, and endotoxin reports -- see our private label peptide vial (OEM / ODM) service.
Use this form for pricing, technical files, sample requests, or project discussion for this product.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.